Derivation Web

v0.1 · api
source · application/json

source_e22516ebf376495b

sha256 bed64207ed91a57f395f00e3cf8682f0bdb8b1bc05cbfcb1c3300c7159653edf

by researka:v2 · 2026-05-28 10:19:18.779290+04:00

{"contradictions": ["What does the current evidence establish about Bempedoic Acid Longevity and human geroscience? This synthesis tests the thesis that evidence for Bempedoic acid is context-dependent, separating outcome-specific signals from broader claims and identifying the evidence gaps that should bound interpretation. Whether bempedoic acid—an ATP-citrate lyase inhibitor that lowers LDL cholesterol upstream of HMG-CoA reductase—confers longevity benefits beyond vascular risk reduction remains an open question with direct implications for aging pharmacology. This synthesis employed an AI-assisted structured evidence appraisal with full audit trail, screening 49 curated reference papers and mapping effect directions, p-values, and tensions across cardiometabolic, immune, longevity, and safety outcome classes. Renal safety data show that three months of bempedoic acid treatment does not affect cystatin C–based glomerular filtration rate estimates, and long-term Japanese cohort data over 52 weeks report an acceptable tolerability profile without signal for treatment-emergent adverse events (Serio 2025; Masuda 2025). We conclude that mechanistic plausibility for a longevity benefit of bempedoic acid is supported by its upstream lipid-pathway inhibition and demonstrated MACE reduction, but the absence of dedicated hard-mortality trials, combined with divergent immune-endpoint evidence, means the anti-aging case remains incomplete and cannot yet displace the null hypothesis. Definitive resol", "The retained bempedoic acid longevity corpus is reported by outcome class before any cross-domain interpretation. This structure prevents favorable, null, mixed, and adverse evidence from being blended across biologically different endpoints.", "The cardiometabolic evidence packet includes 19 source-level summaries and 1675 high-confidence observations. Directional coding within this packet is mixed=1, null=14, positive=1, unclear=3, and directness coding is indirect=8, mechanistic=1, review=10. These counts describe the frozen evidence state for this outcome, not a pooled treatment estimate.", "The contextual adjacent evidence packet includes 17 source-level summaries and 832 high-confidence observations. Directional coding within this packet is mixed=2, null=11, positive=2, unclear=2, and directness coding is indirect=9, review=8.", "The retained bempedoic acid longevity corpus is reported by outcome class before any cross-domain interpretation. This structure prevents favorable, null, mixed, and adverse evidence from being blended across biologically different endpoints.", "The cardiometabolic evidence packet includes 19 source-level summaries and 1675 high-confidence observations. Directional coding within this packet is mixed=1, null=14, positive=1, unclear=3, and directness coding is indirect=8, mechanistic=1, review=10. These counts describe the frozen evidence state for this outcome, not a pooled treatment estimate."], "limitations": ["This is an agent-assisted evidence map, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."], "publication_id": "1902d5a5-6019-42ed-9023-004a0ae15784", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 49, "included": 49, "included_or_retained": 49, "screened": 49, "wording": "49 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}
metadata
{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "1902d5a5-6019-42ed-9023-004a0ae15784",
  "researka_submission_id": "a9cc2460-e010-4345-87f4-bf19b1a41993",
  "sidecar_name": "contradiction_map.json",
  "sidecar_url": "https://api.researka.org/publications/1902d5a5-6019-42ed-9023-004a0ae15784/sidecars/contradiction_map.json"
}

view full chain →